Lisata Therapeutics Inc. (LSTA)
NASDAQ · Healthcare
Lisata Therapeutics Inc. Operating Income 2010–2025
Lisata Therapeutics Inc. annual/quarterly operating income history and growth rate from 2010 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Lisata Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -4.9 M, a 15.48% decrease year-over-year.
- Lisata Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -20.1 M, a 14.31% decrease year-over-year.
- Lisata Therapeutics Inc. annual operating income for 2025 was -18.2 M, a 18.74% decrease from 2024.
- Lisata Therapeutics Inc. annual operating income for 2024 was -22.4 M, a 12.83% decrease from 2023.
- Lisata Therapeutics Inc. annual operating income for 2023 was -25.7 M, a 55.37% decrease from 2022.
- Lisata Therapeutics Inc. annual operating income for 2022 was -57.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lisata Therapeutics Inc. Operating Income — FAQ
Lisata Therapeutics Inc. (LSTA) operating income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Lisata Therapeutics Inc.'s operating income?
Lisata Therapeutics Inc. (LSTA) reported operating income of -$18M for fiscal 2025.
Where can I see LSTA's operating income history?
The chart and table above show Lisata Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.